Barnett S. Kramer, MD, MPH | Authors

PO BOX 27434

Articles

Screening for Prostate Cancer With PSA Testing: Current Status and Future Directions

May 15, 2011

This article will present a detailed review of the body of evidence regarding the PSA assay, with reflections on the resulting future of prostate cancer screening.

The Economics of Prostate Cancer Screening

October 01, 1997

Drs. Benoit and Naslund venture into the complex arena of medical economics and cost-effectiveness analysis of prostate cancer screening-a task that is made all the more difficult because of the dual paucity of data on costs and effectiveness. Their underlying premises are that cost control is a dominant concern in the prostate cancer screening debate and that cost-effectiveness analyses have been used to “justify denial of prostate cancer screening.” Both of these assumptions bear scrutiny.